Total Funding
82
56
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
101602
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
- Mike La Fleur: Founder, President & Director
- Philip Strandwitz: Co-Founder and CEO
About the Company
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety, and other mental health problems including our metabolism and the immune response,
enabling patients to recover quickly from their diseases easily without any pain and suffering.
Holobiome was established in 2015 and is based in Cambridge, Massachusetts.
